| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 3,000 | ₹1.1 0% | 4,7500% |
| - | - | 3,100 | ₹1 0% | 1,7500% |
| 2500% | ₹470 0% | 3,200 | ₹3 0% | 2,0000% |
| - | - | 3,250 | ₹5.15 8.42% | 4,7500% |
| 2500% | ₹322.2 0% | 3,300 | ₹4.7 -21% | 15,250-1.61% |
| 1,0000% | ₹276.05 0% | 3,350 | ₹7.15 0.7% | 4,2500% |
| 1,2500% | ₹240 4.34% | 3,400 | ₹9.1 -26.31% | 48,5006.59% |
| 7500% | ₹184.35 0% | 3,450 | ₹15 -7.97% | 5,5004.76% |
| 13,000-14.75% | ₹116.5 -14.74% | 3,500 | ₹23.9 -12.61% | 39,750-1.85% |
| 2,000166.66% | ₹83.95 -17.61% | 3,550 | ₹41.35 3.11% | 19,00052% |
| 68,00050.27% | ₹58 -18.07% | 3,600 | ₹63.5 5.13% | 33,750-2.17% |
| 1,04,2500.48% | ₹35.1 -27.25% | 3,650 | ₹107 21.86% | 8,7502.94% |
| 80,00010.34% | ₹25 -23.31% | 3,700 | ₹139.9 14.34% | 3,250-7.14% |
| 5,000-28.57% | ₹15.7 -23.03% | 3,750 | ₹160.35 0% | 5000% |
| 29,0000.86% | ₹10.4 -21.8% | 3,800 | - | - |
| 8,75066.66% | ₹6.25 -28.16% | 3,850 | - | - |
| 28,25013% | ₹5.2 -10.34% | 3,900 | - | - |
| 29,250-6.4% | ₹3.2 -1.53% | 4,000 | ₹345 0% | 2500% |
| 2500% | ₹18 0% | 4,100 | - | - |
| 1,2500% | ₹6 0% | 4,200 | - | - |
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
